TNONW

NASD Tenon Medical, Inc. - Warrant
Oct 2, 2026 · 12:42 PM ET DELAYED Market Open

$0.0057 ↓ -0.0009 (-13.64%) Trading Down from the previous close of $0.0066, and at the day’s high of $0.0082

YTD change
-45.71%
vs 20-day SMA
-11.97%
vs 200-day SMA
-51.54%

Price ranges

Previous day
$0.0063 $0.0075
open $0.0069 close $0.0066
-$0.0003 (-4.35%)
Today
$0.0054 $0.0082
open $0.0072 now $0.0057
-$0.0015 (-20.83%)
Past week
$0.0050 $0.0099
from $0.0056 now $0.0057
+$0.0001 (+1.79%)
Past month
$0.0050 $0.0169
from $0.0089 now $0.0057
-$0.0032 (-35.96%)
This year
$0.0042 $0.0430
from $0.0105 now $0.0057
-$0.0048 (-45.71%)

Price & Performance

-0.00 (-17.50%) / 6M

$0.0039$0.0104$0.0168$0.0233Apr 6Jul 15Oct 1

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Poor
  • The stock is 90.1% away from all-time highs of $0.0575
  • TNONW is down 46% since the beginning of the year
  • TNONW is down 68% over the past 12 months
  • TNONW is down 36% over the past 1 month

TNONW reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -63.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable N/A
EPS N/A
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A

Balance sheet & scale

IncomeN/A
RevenueN/A
CashN/A
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Miscellaneous Manufacturing
Market cap N/A

Competitor comparison

TickerCompany PriceChange
SYK Stryker Corporation $272.96 -0.88%
STE STERIS plc $209.34 -0.32%
SNN Smith & Nephew plc Sponsored ADR $26.58 -1.41%
WILYY Demant A/S Unsponsored ADR $24.50 +5.88%
GKOS Glaukos Corp $163.17 -0.62%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.